Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1996
06/18/1996US5527777 Peptide compounds, in particular LHRH-antagonists
06/18/1996US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF
06/18/1996US5527775 Reduction of mammalian neoplasms with phospholipase A2 activating substances
06/18/1996US5527774 Using chymotripsins as zonulolysis causing substances into the interior of eye adjacent to cataractous lens for holding lens capsule in place; couching
06/18/1996US5527773 Use of synthetic peptides to disrupt the cytoskeleton
06/18/1996US5527772 Regulation of cell proliferation and differentiation using peptides
06/18/1996US5527771 Methods and Compositions for treatment of diabetes mellitus, hypoglycemia & other conditions
06/18/1996US5527770 Immunotherapeutic agent derived from bacteria
06/18/1996US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics
06/18/1996US5527698 Useful in detecting the anti-inflammatory potential of various chemical agents
06/18/1996US5527692 Comprising activated recombinant gla-domainless prothrombin, which is cleavable to thrombin
06/18/1996US5527691 Expression vectors containing lambdapl promoter and T1 T2 rRNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and related methods
06/18/1996US5527685 Monoclonal or polyclonal antibodies
06/18/1996US5527682 Purified polypeptide products and their mutants and variants in mammalian cells
06/18/1996US5527679 β5 protein and DNA encoding the same
06/18/1996US5527546 Human interleukin 6 inhibitor
06/18/1996US5527537 Contains natural oils, 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine and water
06/18/1996US5527527 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
06/18/1996CA1338401C Anticoagulant polypeptide
06/13/1996WO1996018105A1 Single chain t-cell receptor
06/13/1996WO1996018103A1 Inhibition of glial cell proliferation
06/13/1996WO1996017953A2 Genetic basis of factor xiii activity
06/13/1996WO1996017951A2 Identification of genes responsible for in vivo survival of microorganisms
06/13/1996WO1996017947A1 Packaging cell lines for generation of high titers of recombinant aav vectors
06/13/1996WO1996017939A1 Isolated herpesvirus saimiri proteins that bind mhc class ii molecules
06/13/1996WO1996017936A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
06/13/1996WO1996017935A2 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
06/13/1996WO1996017934A2 Cloning and recombinant production of crf receptor(s)
06/13/1996WO1996017933A2 Dna encoding a cell growth inhibiting factor and its product
06/13/1996WO1996017931A1 Human vascular ibp-like growth factor
06/13/1996WO1996017929A1 Polypeptide with reduced allergenicity
06/13/1996WO1996017928A1 Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
06/13/1996WO1996017927A2 Reporter cell line
06/13/1996WO1996017925A1 Cytokine designated lerk-7
06/13/1996WO1996017924A2 Novel hedgehog-derived polypeptides
06/13/1996WO1996017874A1 Monoclonal antibody fragments having immunosuppressant activity
06/13/1996WO1996017872A1 Intermediate for producing surfactant peptide
06/13/1996WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands
06/13/1996WO1996017868A1 A novel chemokine expressed in inflamed adenoid, its production and uses
06/13/1996WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins
06/13/1996WO1996017865A2 Genes and gene products for use in the diagnosis of degenerative nerve damage
06/13/1996WO1996017864A1 A 12-kda protein derived from m. tuberculosis useful for treatment of autoimmune diseases
06/13/1996WO1996017863A1 Induction of cytotoxic t-lymphocyte responses
06/13/1996WO1996017862A1 Lhrh antagonists having lactam groups at the n-terminus
06/13/1996WO1996017861A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
06/13/1996WO1996017860A1 New dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals
06/13/1996WO1996017838A1 Malonic acid based matrix metalloproteinase inhibitors
06/13/1996WO1996017633A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
06/13/1996WO1996017631A1 Heat treated blood plasma proteins
06/13/1996WO1996017623A1 Anti-aids drug
06/13/1996WO1996017622A1 Antibodies which inhibit the binding of thrombin to platelets
06/13/1996WO1996017621A1 Correcting biological information transfer using three biological information blocks
06/13/1996WO1996017620A1 Pharmaceutical compositions for the treatment of autoimmune diseases comprising the b-oligomer of pertussis toxin or its subunits
06/13/1996WO1996017619A1 Compounds and methods for controlling reproduction in fish
06/13/1996WO1996017617A1 Neuromedin b receptor antagonists
06/13/1996WO1996017604A1 Use of a nitric oxide (no) donor for the treatment of hypertension during pregnancy
06/13/1996WO1996017600A1 PROTEIN PHOSPHATASE INHIBITION OF TUMOR NECROSIS FACTOR EFFECTS AND NF-kB ACTIVATION
06/13/1996WO1996017596A1 Liposomal interferon hybrid compositions
06/13/1996WO1996011021A3 Treatment of tissues to reduce subsequent response to injury
06/13/1996DE4443390A1 Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten New dipeptide p-Amidinobenzylamide with N-terminal sulfonyl or Aminosulfonylresten
06/13/1996DE4443273A1 Treatment of thromboembolic diseases
06/13/1996CA2207927A1 Packaging cell lines for generation of high titers of recombinant aav vectors
06/13/1996CA2207874A1 Novel dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals
06/13/1996CA2207292A1 Liposomal interferon hybrid compositions
06/13/1996CA2207262A1 A novel chemokine expressed in inflamed adenoid, its production and uses
06/13/1996CA2207036A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
06/13/1996CA2206994A1 Genes and gene products for use in the diagnosis of degenerative nerve damage
06/13/1996CA2206852A1 Polypeptide with reduced allergenicity
06/13/1996CA2206665A1 Malonic acid based matrix metalloproteinase inhibitors
06/13/1996CA2206664A1 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
06/13/1996CA2206640A1 Human vascular ibp-like growth factor
06/13/1996CA2206488A1 Cytokine designated lerk-7
06/13/1996CA2206471A1 Monoclonal antibody fragments having immunosuppressant activity
06/13/1996CA2206321A1 Inhibition of glial cell proliferation
06/13/1996CA2205663A1 Neuromedin b receptor antagonists
06/13/1996CA2204738A1 Induction of cytotoxic t-lymphocyte responses
06/13/1996CA2204144A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
06/12/1996EP0716148A2 Recombinant alphavirus vectors
06/12/1996EP0716146A2 A novel stem cell marker protein, antibodies thereto, compositions thereof and nucleotide sequences encoding said protein
06/12/1996EP0716086A1 Malonic acid based matrix metalloproteinase inhibitors
06/12/1996EP0715854A2 Carcinostatic compositions containing cis-oxalato and one or more other compatible carcinostatic substances
06/12/1996EP0715853A1 Use of glutathione esters for the treatment of pulmonary diseases
06/12/1996EP0715653A1 Humanised antibodies
06/12/1996EP0715633A1 Haemopoietic growth factor antagonists
06/12/1996EP0715619A1 Inhibitors of tnf-alpha secretion
06/12/1996EP0715618A1 Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
06/12/1996EP0715523A1 Purine nucleoside phosphorylase gene therapy for human malignancy
06/12/1996EP0715522A1 Antibody-based treatment of hiv infection
06/12/1996EP0715521A1 Method of inhibiting kaposi's sarcoma
06/12/1996EP0590044A4 Composition and treatment with biologically active peptides having c-terminal substitutions
06/12/1996EP0537318B1 New non-hygroscopic mono-ammonium salts
06/12/1996EP0503044B1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof
06/12/1996EP0497820B1 Ribozyme inhibitors
06/12/1996EP0463151B1 Generation of xenogeneic antibodies
06/12/1996EP0437610B1 Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide
06/12/1996EP0293471B1 Primary biliary cirrhosis autoantigen
06/12/1996CN1124491A Inhibitor of stem cell proliferation and uses thereof
06/12/1996CN1124457A Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
06/12/1996CN1124456A Gonococcal anti-idiotypic antibodies and methods and compositions using them
06/12/1996CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products
1 ... 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 ... 3163